Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
CXXC1
|
ENSG00000154832.10 | CXXC finger protein 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
CXXC1 | hg19_v2_chr18_-_47813940_47814021 | -0.27 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_183989157 | 2.15 |
ENST00000541912.1
|
NUP35
|
nucleoporin 35kDa |
chr3_+_151531810 | 1.61 |
ENST00000232892.7
|
AADAC
|
arylacetamide deacetylase |
chr2_-_217560248 | 1.61 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr6_-_46620522 | 1.60 |
ENST00000275016.2
|
CYP39A1
|
cytochrome P450, family 39, subfamily A, polypeptide 1 |
chr10_-_79397391 | 1.55 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr5_+_115298165 | 1.53 |
ENST00000357872.4
|
AQPEP
|
Aminopeptidase Q |
chr14_+_102027688 | 1.47 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
chr2_+_1488435 | 1.40 |
ENST00000446278.1
ENST00000469607.1 |
TPO
|
thyroid peroxidase |
chr5_+_115298145 | 1.39 |
ENST00000395528.2
|
AQPEP
|
Aminopeptidase Q |
chr3_+_151531859 | 1.34 |
ENST00000488869.1
|
AADAC
|
arylacetamide deacetylase |
chr5_+_78407602 | 1.34 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
chr2_+_235860690 | 1.32 |
ENST00000416021.1
|
SH3BP4
|
SH3-domain binding protein 4 |
chr7_-_27213893 | 1.31 |
ENST00000283921.4
|
HOXA10
|
homeobox A10 |
chr3_-_187009646 | 1.30 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
chr2_+_183989083 | 1.26 |
ENST00000295119.4
|
NUP35
|
nucleoporin 35kDa |
chr22_+_45898712 | 1.26 |
ENST00000455233.1
ENST00000348697.2 ENST00000402984.3 ENST00000262722.7 ENST00000327858.6 ENST00000442170.2 ENST00000340923.5 ENST00000439835.1 |
FBLN1
|
fibulin 1 |
chr4_-_141348789 | 1.25 |
ENST00000414773.1
|
CLGN
|
calmegin |
chr12_-_21927736 | 1.22 |
ENST00000240662.2
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr21_-_43735628 | 1.17 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
chr3_+_186330712 | 1.17 |
ENST00000411641.2
ENST00000273784.5 |
AHSG
|
alpha-2-HS-glycoprotein |
chr6_-_138428613 | 1.13 |
ENST00000421351.3
|
PERP
|
PERP, TP53 apoptosis effector |
chr15_+_45722727 | 1.11 |
ENST00000396650.2
ENST00000558435.1 ENST00000344300.3 |
C15orf48
|
chromosome 15 open reading frame 48 |
chr6_+_28227063 | 1.11 |
ENST00000343684.3
|
NKAPL
|
NFKB activating protein-like |
chr10_-_131762105 | 1.09 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr9_+_35906176 | 1.07 |
ENST00000354323.2
|
HRCT1
|
histidine rich carboxyl terminus 1 |
chr2_+_11752379 | 1.06 |
ENST00000396123.1
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
chr5_-_139422654 | 1.06 |
ENST00000289409.4
ENST00000358522.3 ENST00000378238.4 ENST00000289422.7 ENST00000361474.1 ENST00000545385.1 ENST00000394770.1 ENST00000541337.1 |
NRG2
|
neuregulin 2 |
chr10_-_79397547 | 1.05 |
ENST00000481070.1
|
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr9_-_127269661 | 1.05 |
ENST00000373588.4
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr11_-_116694009 | 1.05 |
ENST00000357780.3
|
APOA4
|
apolipoprotein A-IV |
chr8_+_99076509 | 1.04 |
ENST00000318528.3
|
C8orf47
|
chromosome 8 open reading frame 47 |
chr7_+_116139424 | 1.04 |
ENST00000222693.4
|
CAV2
|
caveolin 2 |
chr14_+_52164820 | 1.02 |
ENST00000554167.1
|
FRMD6
|
FERM domain containing 6 |
chr2_+_238395879 | 1.01 |
ENST00000445024.2
ENST00000338530.4 ENST00000409373.1 |
MLPH
|
melanophilin |
chr13_-_80915059 | 1.01 |
ENST00000377104.3
|
SPRY2
|
sprouty homolog 2 (Drosophila) |
chr10_+_24755416 | 1.00 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr19_-_48389651 | 0.99 |
ENST00000222002.3
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 |
chr1_+_110009215 | 0.99 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr10_-_79397202 | 0.97 |
ENST00000372437.1
ENST00000372408.2 ENST00000372403.4 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr8_+_15397732 | 0.97 |
ENST00000382020.4
ENST00000506802.1 ENST00000509380.1 ENST00000503731.1 |
TUSC3
|
tumor suppressor candidate 3 |
chr3_-_138665969 | 0.97 |
ENST00000330315.3
|
FOXL2
|
forkhead box L2 |
chr18_+_33877654 | 0.95 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr6_+_160769399 | 0.95 |
ENST00000392145.1
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr21_-_43735446 | 0.95 |
ENST00000398431.2
|
TFF3
|
trefoil factor 3 (intestinal) |
chr7_-_99277610 | 0.94 |
ENST00000343703.5
ENST00000222982.4 ENST00000439761.1 ENST00000339843.2 |
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5 |
chr14_-_23624511 | 0.93 |
ENST00000529705.2
|
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
chr8_+_17434689 | 0.92 |
ENST00000398074.3
|
PDGFRL
|
platelet-derived growth factor receptor-like |
chr15_-_45694380 | 0.92 |
ENST00000561148.1
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr6_+_17281802 | 0.91 |
ENST00000509686.1
|
RBM24
|
RNA binding motif protein 24 |
chr3_-_187009798 | 0.90 |
ENST00000337774.5
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
chr18_+_12254318 | 0.89 |
ENST00000320477.9
|
CIDEA
|
cell death-inducing DFFA-like effector a |
chr17_-_6616678 | 0.88 |
ENST00000381074.4
ENST00000293800.6 ENST00000572352.1 ENST00000576323.1 ENST00000573648.1 |
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5 |
chr6_+_160769300 | 0.88 |
ENST00000275300.2
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3 |
chr17_+_1665345 | 0.87 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chrX_-_6145088 | 0.87 |
ENST00000538097.1
|
NLGN4X
|
neuroligin 4, X-linked |
chr4_-_141348763 | 0.87 |
ENST00000509477.1
|
CLGN
|
calmegin |
chr7_+_116166331 | 0.86 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr5_+_127039075 | 0.86 |
ENST00000514853.2
|
CTC-228N24.1
|
CTC-228N24.1 |
chr4_-_138453606 | 0.86 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
chr17_+_77020325 | 0.85 |
ENST00000311661.4
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr5_-_125930877 | 0.85 |
ENST00000510111.2
ENST00000509270.1 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
chr2_-_152118352 | 0.85 |
ENST00000331426.5
|
RBM43
|
RNA binding motif protein 43 |
chr10_-_79397316 | 0.84 |
ENST00000372421.5
ENST00000457953.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr5_-_122372354 | 0.84 |
ENST00000306442.4
|
PPIC
|
peptidylprolyl isomerase C (cyclophilin C) |
chr22_-_36220420 | 0.84 |
ENST00000473487.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr12_-_53297432 | 0.84 |
ENST00000546900.1
|
KRT8
|
keratin 8 |
chr14_+_104552016 | 0.83 |
ENST00000551177.1
ENST00000546892.2 ENST00000455920.2 |
ASPG
|
asparaginase homolog (S. cerevisiae) |
chr4_+_100495864 | 0.83 |
ENST00000265517.5
ENST00000422897.2 |
MTTP
|
microsomal triglyceride transfer protein |
chr3_+_157261116 | 0.83 |
ENST00000468043.1
ENST00000459838.1 ENST00000461040.1 ENST00000449199.2 ENST00000426338.2 |
C3orf55
|
chromosome 3 open reading frame 55 |
chr1_+_110009150 | 0.83 |
ENST00000401021.3
|
SYPL2
|
synaptophysin-like 2 |
chr20_-_42939782 | 0.82 |
ENST00000396825.3
|
FITM2
|
fat storage-inducing transmembrane protein 2 |
chr17_+_72426891 | 0.82 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr21_+_45879814 | 0.81 |
ENST00000596691.1
|
LRRC3DN
|
LRRC3 downstream neighbor (non-protein coding) |
chr7_+_55086794 | 0.81 |
ENST00000275493.2
ENST00000442591.1 |
EGFR
|
epidermal growth factor receptor |
chrX_-_17878827 | 0.81 |
ENST00000360011.1
|
RAI2
|
retinoic acid induced 2 |
chr8_+_19171128 | 0.80 |
ENST00000265807.3
|
SH2D4A
|
SH2 domain containing 4A |
chr15_-_74658493 | 0.80 |
ENST00000419019.2
ENST00000569662.1 |
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1 |
chr2_-_86564776 | 0.80 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
chr10_-_54531406 | 0.79 |
ENST00000373968.3
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble |
chr22_-_24384260 | 0.79 |
ENST00000248935.5
|
GSTT1
|
glutathione S-transferase theta 1 |
chr5_-_115152651 | 0.79 |
ENST00000250535.4
|
CDO1
|
cysteine dioxygenase type 1 |
chr5_+_140593509 | 0.79 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
chr2_-_151395525 | 0.78 |
ENST00000439275.1
|
RND3
|
Rho family GTPase 3 |
chr2_-_106015527 | 0.77 |
ENST00000344213.4
ENST00000358129.4 |
FHL2
|
four and a half LIM domains 2 |
chr8_-_9008206 | 0.77 |
ENST00000310455.3
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr2_-_86564740 | 0.77 |
ENST00000540790.1
ENST00000428491.1 |
REEP1
|
receptor accessory protein 1 |
chr19_-_36004543 | 0.77 |
ENST00000339686.3
ENST00000447113.2 ENST00000440396.1 |
DMKN
|
dermokine |
chr5_-_78365437 | 0.76 |
ENST00000380311.4
ENST00000540686.1 ENST00000255189.3 |
DMGDH
|
dimethylglycine dehydrogenase |
chr4_+_8271471 | 0.76 |
ENST00000307358.2
ENST00000382512.3 |
HTRA3
|
HtrA serine peptidase 3 |
chr7_-_45960850 | 0.76 |
ENST00000381083.4
ENST00000381086.5 ENST00000275521.6 |
IGFBP3
|
insulin-like growth factor binding protein 3 |
chr7_+_116139744 | 0.76 |
ENST00000343213.2
|
CAV2
|
caveolin 2 |
chr17_+_12569306 | 0.76 |
ENST00000425538.1
|
MYOCD
|
myocardin |
chr12_-_66275350 | 0.75 |
ENST00000536648.1
|
RP11-366L20.2
|
Uncharacterized protein |
chr6_+_138725343 | 0.74 |
ENST00000607197.1
ENST00000367697.3 |
HEBP2
|
heme binding protein 2 |
chr5_-_146889619 | 0.74 |
ENST00000343218.5
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chr16_+_66410244 | 0.74 |
ENST00000562048.1
ENST00000568155.2 |
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
chr17_+_39968926 | 0.74 |
ENST00000585664.1
ENST00000585922.1 ENST00000429461.1 |
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr3_+_89156674 | 0.73 |
ENST00000336596.2
|
EPHA3
|
EPH receptor A3 |
chr16_+_1203194 | 0.73 |
ENST00000348261.5
ENST00000358590.4 |
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit |
chr19_+_45312347 | 0.73 |
ENST00000270233.6
ENST00000591520.1 |
BCAM
|
basal cell adhesion molecule (Lutheran blood group) |
chr15_-_71055769 | 0.73 |
ENST00000539319.1
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr14_-_53417732 | 0.73 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
chr3_+_14860831 | 0.73 |
ENST00000543601.1
|
FGD5
|
FYVE, RhoGEF and PH domain containing 5 |
chr2_+_120187465 | 0.73 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
chr18_-_48351743 | 0.73 |
ENST00000588444.1
ENST00000256425.2 ENST00000428869.2 |
MRO
|
maestro |
chr17_+_32612687 | 0.72 |
ENST00000305869.3
|
CCL11
|
chemokine (C-C motif) ligand 11 |
chr7_+_100318423 | 0.72 |
ENST00000252723.2
|
EPO
|
erythropoietin |
chr19_-_2050852 | 0.71 |
ENST00000541165.1
ENST00000591601.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
chr17_+_79679299 | 0.71 |
ENST00000331531.5
|
SLC25A10
|
solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10 |
chr1_-_228135599 | 0.70 |
ENST00000272164.5
|
WNT9A
|
wingless-type MMTV integration site family, member 9A |
chr7_-_107642348 | 0.70 |
ENST00000393561.1
|
LAMB1
|
laminin, beta 1 |
chr3_+_15643245 | 0.70 |
ENST00000303498.5
ENST00000437172.1 |
BTD
|
biotinidase |
chr11_-_72301463 | 0.70 |
ENST00000475807.2
|
PDE2A
|
phosphodiesterase 2A, cGMP-stimulated |
chr22_-_24384240 | 0.69 |
ENST00000439996.2
ENST00000417870.1 |
GSTT1
|
glutathione S-transferase theta 1 |
chr7_-_128001658 | 0.69 |
ENST00000489835.2
ENST00000464607.1 ENST00000489517.1 ENST00000446477.2 ENST00000535159.1 ENST00000435512.1 ENST00000495931.1 |
PRRT4
|
proline-rich transmembrane protein 4 |
chr15_-_45670717 | 0.69 |
ENST00000558163.1
ENST00000558336.1 |
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr17_-_19265855 | 0.69 |
ENST00000440841.1
ENST00000395615.1 ENST00000461069.2 |
B9D1
|
B9 protein domain 1 |
chr4_+_124320665 | 0.69 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr11_+_46402297 | 0.69 |
ENST00000405308.2
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr7_+_95401851 | 0.69 |
ENST00000447467.2
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1 |
chr2_-_179343226 | 0.68 |
ENST00000434643.2
|
FKBP7
|
FK506 binding protein 7 |
chr19_+_7584088 | 0.68 |
ENST00000394341.2
|
ZNF358
|
zinc finger protein 358 |
chr3_-_120169828 | 0.67 |
ENST00000424703.2
ENST00000469005.1 |
FSTL1
|
follistatin-like 1 |
chr11_+_117947782 | 0.67 |
ENST00000522307.1
ENST00000523251.1 ENST00000437212.3 ENST00000522824.1 ENST00000522151.1 |
TMPRSS4
|
transmembrane protease, serine 4 |
chr15_-_48937982 | 0.67 |
ENST00000316623.5
|
FBN1
|
fibrillin 1 |
chr15_+_63682335 | 0.67 |
ENST00000559379.1
ENST00000559821.1 |
RP11-321G12.1
|
RP11-321G12.1 |
chr4_-_138453559 | 0.67 |
ENST00000511115.1
|
PCDH18
|
protocadherin 18 |
chr7_+_89874483 | 0.66 |
ENST00000389297.4
ENST00000316089.8 |
C7orf63
|
chromosome 7 open reading frame 63 |
chr12_+_31079652 | 0.66 |
ENST00000546076.1
ENST00000535215.1 ENST00000544427.1 ENST00000261177.9 |
TSPAN11
|
tetraspanin 11 |
chr1_+_6845578 | 0.66 |
ENST00000467404.2
ENST00000439411.2 |
CAMTA1
|
calmodulin binding transcription activator 1 |
chr8_+_19171196 | 0.66 |
ENST00000518040.1
|
SH2D4A
|
SH2 domain containing 4A |
chr19_-_15311713 | 0.66 |
ENST00000601011.1
ENST00000263388.2 |
NOTCH3
|
notch 3 |
chr4_+_175204865 | 0.66 |
ENST00000505124.1
|
CEP44
|
centrosomal protein 44kDa |
chr14_+_64854958 | 0.66 |
ENST00000555709.2
ENST00000554739.1 ENST00000554768.1 ENST00000216605.8 |
MTHFD1
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase |
chr7_-_107643567 | 0.65 |
ENST00000393559.1
ENST00000439976.1 ENST00000393560.1 |
LAMB1
|
laminin, beta 1 |
chr17_-_17480779 | 0.65 |
ENST00000395782.1
|
PEMT
|
phosphatidylethanolamine N-methyltransferase |
chr17_+_72427477 | 0.65 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr15_+_69857515 | 0.65 |
ENST00000559477.1
|
RP11-279F6.1
|
RP11-279F6.1 |
chr15_+_84841242 | 0.64 |
ENST00000558195.1
|
RP11-182J1.16
|
ubiquitin-conjugating enzyme E2Q family member 2-like |
chr10_+_135340859 | 0.64 |
ENST00000252945.3
ENST00000421586.1 ENST00000418356.1 |
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1 |
chr4_+_175205162 | 0.64 |
ENST00000503053.1
|
CEP44
|
centrosomal protein 44kDa |
chr9_-_19127474 | 0.64 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
chr11_-_62457371 | 0.64 |
ENST00000317449.4
|
LRRN4CL
|
LRRN4 C-terminal like |
chr6_-_85473156 | 0.64 |
ENST00000606784.1
ENST00000606325.1 |
TBX18
|
T-box 18 |
chr6_-_168476511 | 0.64 |
ENST00000440994.2
|
FRMD1
|
FERM domain containing 1 |
chr1_-_227506158 | 0.64 |
ENST00000366769.3
|
CDC42BPA
|
CDC42 binding protein kinase alpha (DMPK-like) |
chr5_+_15500280 | 0.63 |
ENST00000504595.1
|
FBXL7
|
F-box and leucine-rich repeat protein 7 |
chr1_-_169455169 | 0.63 |
ENST00000367804.4
ENST00000236137.5 |
SLC19A2
|
solute carrier family 19 (thiamine transporter), member 2 |
chr1_+_198126209 | 0.63 |
ENST00000367383.1
|
NEK7
|
NIMA-related kinase 7 |
chr22_-_36236623 | 0.63 |
ENST00000405409.2
|
RBFOX2
|
RNA binding protein, fox-1 homolog (C. elegans) 2 |
chr1_-_145039835 | 0.63 |
ENST00000533259.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
chr2_-_128408105 | 0.62 |
ENST00000409254.1
|
LIMS2
|
LIM and senescent cell antigen-like domains 2 |
chr6_-_11044509 | 0.62 |
ENST00000354666.3
|
ELOVL2
|
ELOVL fatty acid elongase 2 |
chr22_-_28490123 | 0.62 |
ENST00000442232.1
|
TTC28
|
tetratricopeptide repeat domain 28 |
chr9_-_127269488 | 0.62 |
ENST00000455734.1
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1 |
chr1_-_46642154 | 0.62 |
ENST00000540385.1
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
chr8_+_145726472 | 0.62 |
ENST00000528430.1
|
PPP1R16A
|
protein phosphatase 1, regulatory subunit 16A |
chr2_-_179343268 | 0.62 |
ENST00000424785.2
|
FKBP7
|
FK506 binding protein 7 |
chr3_+_112929850 | 0.62 |
ENST00000464546.1
|
BOC
|
BOC cell adhesion associated, oncogene regulated |
chr4_-_80994619 | 0.62 |
ENST00000404191.1
|
ANTXR2
|
anthrax toxin receptor 2 |
chr22_+_38203996 | 0.61 |
ENST00000451984.1
|
GCAT
|
glycine C-acetyltransferase |
chr11_-_63258601 | 0.61 |
ENST00000540857.1
ENST00000539221.1 ENST00000301790.4 |
HRASLS5
|
HRAS-like suppressor family, member 5 |
chr10_+_76969909 | 0.61 |
ENST00000298468.5
ENST00000543351.1 |
VDAC2
|
voltage-dependent anion channel 2 |
chr16_-_2301563 | 0.60 |
ENST00000562238.1
ENST00000566379.1 ENST00000301729.4 |
ECI1
|
enoyl-CoA delta isomerase 1 |
chr3_-_119379719 | 0.60 |
ENST00000493094.1
|
POPDC2
|
popeye domain containing 2 |
chr1_-_24469602 | 0.60 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
chr6_+_46620676 | 0.60 |
ENST00000371347.5
ENST00000411689.2 |
SLC25A27
|
solute carrier family 25, member 27 |
chr12_+_8849773 | 0.60 |
ENST00000541044.1
|
RIMKLB
|
ribosomal modification protein rimK-like family member B |
chrX_+_134124968 | 0.60 |
ENST00000330288.4
|
SMIM10
|
small integral membrane protein 10 |
chr14_+_37667193 | 0.60 |
ENST00000539062.2
|
MIPOL1
|
mirror-image polydactyly 1 |
chr4_-_47916613 | 0.60 |
ENST00000381538.3
ENST00000329043.3 |
NFXL1
|
nuclear transcription factor, X-box binding-like 1 |
chr5_+_140602904 | 0.60 |
ENST00000515856.2
ENST00000239449.4 |
PCDHB14
|
protocadherin beta 14 |
chr4_-_80994471 | 0.60 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
chr9_+_139839686 | 0.60 |
ENST00000371634.2
|
C8G
|
complement component 8, gamma polypeptide |
chrX_-_154255143 | 0.60 |
ENST00000453950.1
ENST00000423959.1 |
F8
|
coagulation factor VIII, procoagulant component |
chr10_-_103603568 | 0.60 |
ENST00000356640.2
|
KCNIP2
|
Kv channel interacting protein 2 |
chr1_+_63788730 | 0.59 |
ENST00000371116.2
|
FOXD3
|
forkhead box D3 |
chr14_+_75536280 | 0.59 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
chr1_+_150229554 | 0.58 |
ENST00000369111.4
|
CA14
|
carbonic anhydrase XIV |
chr6_+_17393888 | 0.58 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr2_-_118943930 | 0.58 |
ENST00000449075.1
ENST00000414886.1 ENST00000449819.1 |
AC093901.1
|
AC093901.1 |
chr6_-_46424599 | 0.58 |
ENST00000405162.1
|
RCAN2
|
regulator of calcineurin 2 |
chr4_-_135122903 | 0.58 |
ENST00000421491.3
ENST00000529122.2 |
PABPC4L
|
poly(A) binding protein, cytoplasmic 4-like |
chr11_-_18258342 | 0.58 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr6_+_5085572 | 0.58 |
ENST00000405617.2
|
PPP1R3G
|
protein phosphatase 1, regulatory subunit 3G |
chr6_+_86159821 | 0.58 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
chr19_-_12267524 | 0.58 |
ENST00000455799.1
ENST00000355738.1 ENST00000439556.2 ENST00000542938.1 |
ZNF625
|
zinc finger protein 625 |
chr1_+_10057274 | 0.57 |
ENST00000294435.7
|
RBP7
|
retinol binding protein 7, cellular |
chr4_+_108911036 | 0.57 |
ENST00000505878.1
|
HADH
|
hydroxyacyl-CoA dehydrogenase |
chr16_+_85646763 | 0.57 |
ENST00000411612.1
ENST00000253458.7 |
GSE1
|
Gse1 coiled-coil protein |
chr2_+_138721850 | 0.57 |
ENST00000329366.4
ENST00000280097.3 |
HNMT
|
histamine N-methyltransferase |
chr11_+_33037401 | 0.57 |
ENST00000241051.3
|
DEPDC7
|
DEP domain containing 7 |
chr17_+_39975544 | 0.57 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chrX_-_17879356 | 0.57 |
ENST00000331511.1
ENST00000415486.3 ENST00000545871.1 ENST00000451717.1 |
RAI2
|
retinoic acid induced 2 |
chr6_+_19837592 | 0.57 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
chr15_+_99645277 | 0.57 |
ENST00000336292.6
ENST00000328642.7 |
SYNM
|
synemin, intermediate filament protein |
chr17_+_72428218 | 0.56 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr5_+_148651409 | 0.56 |
ENST00000296721.4
|
AFAP1L1
|
actin filament associated protein 1-like 1 |
chr8_+_94712752 | 0.56 |
ENST00000522324.1
ENST00000522803.1 ENST00000423990.2 |
FAM92A1
|
family with sequence similarity 92, member A1 |
chr17_+_77020224 | 0.56 |
ENST00000339142.2
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.5 | 1.6 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
0.5 | 2.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.5 | 2.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.4 | 4.6 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.3 | 1.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 1.7 | GO:0007538 | primary sex determination(GO:0007538) |
0.3 | 2.7 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.3 | 1.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.3 | 4.0 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.3 | 1.2 | GO:0031455 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.3 | 0.9 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.3 | 0.3 | GO:1903093 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.3 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 0.5 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
0.3 | 1.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.7 | GO:1903384 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
0.2 | 0.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.2 | 0.9 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.2 | 1.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.9 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.9 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.2 | 0.7 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.2 | 0.7 | GO:0060829 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 1.1 | GO:1902378 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.2 | 1.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.2 | 1.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.2 | 0.6 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.2 | 0.8 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.2 | 3.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 2.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 | 1.0 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 0.6 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.2 | 0.4 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.2 | 0.6 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.5 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.2 | 0.9 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
0.2 | 1.4 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.2 | 1.2 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.2 | 0.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.2 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.2 | 0.5 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.2 | 0.5 | GO:1901207 | mammary placode formation(GO:0060596) regulation of heart looping(GO:1901207) |
0.2 | 0.5 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.2 | 0.6 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.2 | 0.8 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.2 | 1.4 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 0.6 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.2 | 0.6 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
0.2 | 1.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.4 | GO:1903413 | cellular response to bile acid(GO:1903413) response to iron ion starvation(GO:1990641) |
0.1 | 0.7 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.1 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.1 | 1.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.4 | GO:0071586 | prenylated protein catabolic process(GO:0030327) CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.1 | 0.7 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.1 | 0.5 | GO:0003193 | pulmonary valve formation(GO:0003193) visceral motor neuron differentiation(GO:0021524) foramen ovale closure(GO:0035922) |
0.1 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.4 | GO:0032903 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.1 | 0.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 1.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.4 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.1 | 0.6 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 0.7 | GO:0030421 | defecation(GO:0030421) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.1 | 0.3 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 1.6 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 1.7 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.9 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.1 | 0.9 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.1 | 3.7 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.4 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.1 | 1.4 | GO:0003360 | brainstem development(GO:0003360) |
0.1 | 0.6 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 0.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.4 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.4 | GO:1905065 | protein-pyridoxal-5-phosphate linkage(GO:0018352) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.3 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.1 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.6 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.1 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.1 | 0.3 | GO:0018013 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.1 | 0.5 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.4 | GO:1905123 | regulation of endosome organization(GO:1904978) regulation of glucosylceramidase activity(GO:1905123) |
0.1 | 0.9 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 1.1 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.4 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 1.9 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 1.1 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.3 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.5 | GO:0044856 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.1 | 0.8 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 0.6 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.5 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.3 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.1 | 0.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
0.1 | 0.3 | GO:0035910 | inhibition of neuroepithelial cell differentiation(GO:0002085) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) auditory receptor cell fate determination(GO:0042668) negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of pro-B cell differentiation(GO:2000974) |
0.1 | 1.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.1 | 0.7 | GO:0045837 | negative regulation of mitochondrial membrane potential(GO:0010917) negative regulation of membrane potential(GO:0045837) |
0.1 | 0.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.7 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.7 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.9 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.3 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.1 | 0.2 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.1 | 0.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.1 | 0.3 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.5 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.1 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.3 | GO:0072143 | mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.8 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.7 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.1 | 0.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.2 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.1 | 0.2 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
0.1 | 0.5 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.1 | 0.3 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.4 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.4 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.1 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.3 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.1 | 0.5 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.4 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.2 | GO:0071262 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
0.1 | 0.4 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.2 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.2 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.2 | GO:0071301 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
0.1 | 0.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.1 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.1 | 0.4 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.3 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 1.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.1 | 3.3 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 1.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.1 | 2.1 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.1 | 0.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 1.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.2 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 0.3 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.1 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.6 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.5 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 0.1 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 1.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.3 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) response to cortisol(GO:0051414) |
0.1 | 0.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 1.3 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.0 | 1.4 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.0 | 0.3 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.2 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.0 | 0.1 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.0 | 1.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.9 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.1 | GO:0019516 | lactate oxidation(GO:0019516) |
0.0 | 0.1 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.0 | 1.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.2 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.0 | 0.3 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.7 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.0 | 1.0 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 0.9 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.0 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 1.0 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.5 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 1.0 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.8 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.0 | 2.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 1.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.3 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) spinal cord dorsal/ventral patterning(GO:0021513) ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.0 | 0.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.3 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.0 | 0.1 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.0 | 0.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.1 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.0 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.0 | 0.4 | GO:0061458 | reproductive system development(GO:0061458) |
0.0 | 0.2 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 1.7 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.2 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.0 | 0.1 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.0 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.0 | 0.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.2 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.0 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.4 | GO:0072513 | semicircular canal morphogenesis(GO:0048752) positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.4 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
0.0 | 0.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.0 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 1.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.3 | GO:0071692 | sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.0 | 0.2 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.6 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 0.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.0 | 2.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.0 | 0.3 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.0 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.1 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 0.3 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.0 | 0.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.0 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.0 | 1.0 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.0 | 0.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.0 | 0.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.1 | GO:1902103 | metaphase/anaphase transition of meiotic cell cycle(GO:0044785) regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902102) negative regulation of metaphase/anaphase transition of meiotic cell cycle(GO:1902103) regulation of meiotic chromosome separation(GO:1905132) negative regulation of meiotic chromosome separation(GO:1905133) |
0.0 | 0.1 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.0 | 0.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.0 | 0.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.8 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 1.1 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.4 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 2.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 0.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.0 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.4 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.3 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:2000051 | Wnt receptor catabolic process(GO:0038018) negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.0 | 0.2 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.0 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.0 | 0.3 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.0 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.3 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.0 | 0.7 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.4 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:1903772 | virus maturation(GO:0019075) regulation of viral budding via host ESCRT complex(GO:1903772) |
0.0 | 0.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.0 | 0.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.0 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.2 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.0 | 0.4 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.1 | GO:0006781 | succinyl-CoA pathway(GO:0006781) |
0.0 | 0.3 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.0 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 2.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.4 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
0.0 | 0.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.0 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.5 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.0 | 0.1 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.0 | 0.4 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.1 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.1 | GO:0060763 | mammary gland fat development(GO:0060611) mammary duct terminal end bud growth(GO:0060763) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.1 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.6 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.2 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.0 | 0.6 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.0 | 0.1 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.0 | 0.1 | GO:0051532 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.9 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.5 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.5 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.0 | 0.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.0 | 0.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 0.8 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 2.3 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.0 | 0.1 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) |
0.0 | 0.2 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 1.3 | GO:0021762 | substantia nigra development(GO:0021762) |
0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.3 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.3 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.7 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.7 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
0.0 | 1.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.6 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.4 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.0 | 0.7 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 2.9 | GO:0007586 | digestion(GO:0007586) |
0.0 | 1.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.0 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.1 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.0 | 0.0 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0044108 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
0.0 | 0.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.0 | 0.3 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.4 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.0 | 0.3 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.9 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.0 | 0.1 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.2 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.3 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.0 | 0.1 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.0 | 0.3 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.0 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.3 | GO:0060444 | branching involved in mammary gland duct morphogenesis(GO:0060444) |
0.0 | 0.1 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.4 | GO:0007130 | synaptone |